ADA Scientific Sessions 2026 Abstract · Jun 5, 2026

Apolipoprotein A4 Improves Aging-Related Glucose Homeostasis

By BASHIR N, LARUSSA Z, SHI H et al.

Introduction and Objective: Aging is associated with a decline in hepatic fatty acid oxidation, leading to increased hepatic lipid accumulation, impaired glucose tolerance, and a higher risk of age-related type 2 diabetes. Apolipoprotein A4 (APOA4) has been shown to attenuate high-fat diet-induced hepatic lipid accumulation and improve glucose tolerance. Our preliminary data show that old mice exhibit lower plasma APOA4 levels. We hypothesized that APOA4 would reduce age-related hepatic lipid accumulation by enhancing fatty acid oxidation and improving glucose homeostasis. Methods: To test this, male mice fed a chow diet received a 4-week infusion of either saline or APOA4 at a physiological dose. Hepatic fatty acid oxidation, hepatic lipid accumulation, and glucose tolerance were assessed in both young and old mice with or without APOA4 treatment. Results: APOA4 infusion increased hepatic fatty acid oxidation, reduced liver weight and hepatic lipid accumulation, and improved glucose tolerance in old mice, but not in young mice. Conclusion: In conclusion, maintaining APOA4 level enhances hepatic fatty acid oxidation, decreases hepatic lipid accumulation, and promotes glucose tolerance during aging. Disclosure: N. Bashir: None. Z. LaRussa: None. H. Shi: None. C. Lo: None.

doi.org/10.2337/db26-2491-pInterventions

AgingResearch.News